Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1778461000001119 | Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1778471000001112 | Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Has VMP | Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Has specific active ingredient | Onasemnogene abeparvovec | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Has dispensed dose form | Conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zolgensma 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 4 x 8.3ml vials | Is a | True | Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 6.6-7.0kg) solution for infusion 1 x 5.5ml + 4 x 8.3ml vials 1 pack | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR